Client News

Propanc Biopharma’s (OTC Pink: PPCB) Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP

MELBOURNE, Australia, December 13, 2023–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s joint researcher, Mrs. Belén Toledo Cutillas, has commenced an internship at the Cancer Center Amsterdam – vUMC (University Medical Centers). In […]

Correlate Energy Corp. (OTCQB: CIPI) Breaks Ground on Its Largest Corporate Campus Project to Date in Reading, Pennsylvania

BOISE, Idaho, Dec. 13, 2023 (GLOBE NEWSWIRE) — Correlate Energy Corp. (OTCQB: CIPI) (“Correlate” or the “Company”), a growth-oriented distributed energy company, is excited to announce that construction has begun on its solar project in Reading, Pennsylvania. The project originally started at 3.8 MW and has grown in size to 5.2 MW, marking a significant […]

Nuvve (Nasdaq: NVVE) Releases Letter to Stockholders

SAN DIEGO, Dec. 13, 2023 /PRNewswire/ — Nuvve Holding Corp. (Nasdaq: NVVE), a global technology leader accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) platform, today released a letter to stockholders providing details on its recent performance highlights, product and services offerings, growth strategy and financial outlook. Nuvve’s management team will be hosting a stockholder Q&A […]

Correlate Energy Corp. (OTCQB: CIPI) Successfully Completes Solar Project at American Tire Distributors Headquarters, Showcasing the Economic Benefits of Clean Energy

BOISE, Idaho, Dec. 12, 2023 (GLOBE NEWSWIRE) — Correlate Energy Corp. (OTCQB: CIPI) (“Correlate” or the “Company”), a growth-oriented distributed energy company, is pleased to announce the successful commissioning of a solar project at the headquarters of American Tire Distributors (ATD) in Huntersville, North Carolina. This initiative underscores the harmony between sustainability and profitability. As […]

Amesite (NASDAQ: AMST) Announces Strategic Five-Year Partnership to Expand Workforce Development with West Virginia Northern Community College

DETROIT, Dec. 12, 2023 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announces a five-year partnership with West Virginia Northern Community College (WVNCC). Dr. Ann Marie Sastry, CEO of Amesite, commented on the new partnership. “WVNCC’s Workforce Development Program is very effectively […]

Nuvve (Nasdaq: NVVE) Continues Scaling Effort Into Japanese Stationary Battery Segment

V2G leader in partnership with Toyota Tsusho and Chubu Electric Power Miraiz now integrating stationary battery systems produced and deployed by Nissin Electric Company. SAN DIEGO, Dec. 12, 2023 /PRNewswire/ — Nuvve Holding Corp. (Nasdaq: NVVE), a global cleantech company electrifying the planet through its intelligent energy platform, along with Toyota Tsusho Corporation and Japan’s Chubu Electric Power Miraiz Company (Chubu) […]

James Nathanielsz, CEO of Propanc Biopharma, Inc., (QB – PPCB) is Featured in an Interview With SmallCapsDaily

Propanc CEO, James Nathanielsz Discusses the Company’s Groundbreaking Therapy, PRP, and its Potential to Revolutionize Cancer Treatment NEW YORK, NY – (NewMediaWire) – December 12, 2023 – Propanc Biopharma, Inc. (QB – PPCB), is pleased to announce its CEO, James Nathanielsz, recently conducted an interview with SmallCapsDaily discussing the Company’s recent developments, including the initiation […]

Skye Bioscience (OTCQB: SKYE) Responds to OTC Markets Promotional Policy

San Diego, California–(Newsfile Corp. – December 8, 2023) – Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing drugs targeting the endocannabinoid system, focusing on metabolic conditions and glaucoma, has received a request by OTC Markets Group Inc. (“OTC Markets”) to issue this statement about promotional activity concerning its common shares […]

Skye (OTCQB: SKYE) Announces Clinical Development Plan in Obesity for Differentiated Peripheral CB1 Inhibitor, Nimacimab

Skye files IND with FDA Division of Diabetes, Lipid Disorders and Obesity Phase 2 study in patients with obesity and chronic kidney disease planned to initiate in first half of 2024 SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a pharmaceutical company developing drugs targeting the endocannabinoid system, announced […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.